Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow-to-Debt Ratio
Chengdu Easton Biopharmaceuticals Co Ltd cash flow-to-debt ratio. Chengdu Easton Biopharmaceuticals Co Ltd (688513) has a Cash Flow-to-Debt Ratio of 0.09x as of September 2025, meaning its operating cash flow of CN¥61.35 Million could theoretically repay 0% of its total liabilities (CN¥692.94 Million) in one year. Check Chengdu Easton Biopharmaceuticals Co Ltd (688513) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2024)
Cash flow-to-debt ratio of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2024. Historical debt coverage capacity for Chengdu Easton Biopharmaceuticals Co Ltd across 12 annual periods. Check 688513 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Chengdu Easton Biopharmaceuticals Co Ltd Cash Flow-to-Debt Ratio by Year (2013–2024)
Chengdu Easton Biopharmaceuticals Co Ltd cash flow-to-debt ratio by year from 2013 to 2024. Year-by-year debt coverage analysis for Chengdu Easton Biopharmaceuticals Co Ltd. For the full cash flow conversion analysis, see Chengdu Easton Biopharmaceuticals Co Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.37x | CN¥263.24 Million | CN¥702.21 Million | ▲ +1.2% |
| 2023 | 0.37x | CN¥275.25 Million | CN¥743.33 Million | ▲ +39.7% |
| 2022 | 0.27x | CN¥151.94 Million | CN¥573.08 Million | ▼ -13.1% |
| 2021 | 0.31x | CN¥147.60 Million | CN¥483.60 Million | ▼ -15.1% |
| 2020 | 0.36x | CN¥156.52 Million | CN¥435.61 Million | ▼ -26.6% |
| 2019 | 0.49x | CN¥141.83 Million | CN¥289.64 Million | ▼ -39.1% |
| 2018 | 0.80x | CN¥166.79 Million | CN¥207.50 Million | ▲ +37.6% |
| 2017 | 0.58x | CN¥85.70 Million | CN¥146.70 Million | ▼ -28.2% |
| 2016 | 0.81x | CN¥106.06 Million | CN¥130.43 Million | ▼ -30.2% |
| 2015 | 1.16x | CN¥50.57 Million | CN¥43.42 Million | ▲ +99.1% |
| 2014 | 0.59x | CN¥46.71 Million | CN¥79.85 Million | ▲ +79.4% |
| 2013 | 0.33x | CN¥28.12 Million | CN¥86.24 Million | — |